Regional variations in guideline-concordant breast cancer care across Nova Scotia - New Publication

Our team has published new research examining neoadjuvant chemotherapy prescribing patterns for aggressive breast cancer subtypes across Nova Scotia, and whether receipt of this treatment varies by geographic health zone.

Research team

Andrea Mayo, Hanna Stewart, Tongtong Li, Cameron Penny, Rachel Hemsworth, Ashley Drohan, Katerina Neumann, Boris Gala-Lopez, Richard T. Spence, and Gregory Knapp

Breast Health Research Unit, IWK Health Centre & Department of Surgery / General Surgery Research Collaborative, Dalhousie University, Halifax, NS

Published in Current Oncology (MDPI)

To Read More: Regional Variations in Guideline Concordance for Women with Triple-Negative and HER2+ Breast Cancer in Nova Scotia | MDPI Citation:

Mayo, A.; Stewart, H.; Li, T.; Penny, C.; Hemsworth, R.; Drohan, A.; Neumann, K.; Gala-Lopez, B.; Spence, R.T.; Knapp, G. Regional Variations in Guideline Concordance for Women with Triple-Negative and HER2+ Breast Cancer in Nova Scotia. Curr. Oncol. 2026, 33, 332. https://doi.org/10.3390/curroncol33060332